Search

Takeda Pharmaceutical Co Ltd ADR

Cerrado

SectorSanidad

17.39 -1.42

Resumen

Variación precio

24h

Actual

Mínimo

17.26

Máximo

17.64

Métricas clave

By Trading Economics

Ingresos

138B

113B

Ventas

105B

1.2T

P/B

Media del Sector

42.622

57.002

BPA

0.48

Rentabilidad por dividendo

3.53

Margen de beneficios

9.279

Empleados

47,029

EBITDA

180B

337B

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+80.43% upside

Dividendos

By Acuity

Rentabilidad por dividendo

Media del Sector

3.53%

2.22%

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

351M

56B

Apertura anterior

18.81

Cierre anterior

17.39

Noticias sobre sentimiento de mercado

By Acuity

100%

0%

328 / 340 Clasificación en Healthcare

Takeda Pharmaceutical Co Ltd ADR Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

17 ago 2026, 23:56 UTC

News
Social Media

Axon Enterprise shares are lower in after-market hours, following a report highlighting high valuations and recent military contracts from Bulgaria.

17 ago 2026, 23:56 UTC

News

Warner Bros Discovery shares are lower in after-market trading amid ongoing litigation over its merger with Paramount, which faces a $1.9 billion bond request.

17 ago 2026, 23:56 UTC

News

Allstate Corp shares are lower in after-market hours amid broader market weakness. Geopolitical concerns are affecting trading sentiment despite recent positive earnings highlights.

17 ago 2026, 23:56 UTC

News

Replimune Group Inc shares are lower in after-market hours amid negative sentiment from multiple class action lawsuits alleging securities fraud and misleading statements.

17 ago 2026, 23:46 UTC

Correlated Moves
News

ManpowerGroup Inc shares are lower in after-market hours amid concerns over declining sales and profitability, with operating margins reported at just 1.5%.

17 ago 2026, 23:46 UTC

News

Wix.com Ltd faces a securities class action lawsuit over alleged false statements about its AI offerings, contributing to shares trading roughly flat in after-hours activity.

17 ago 2026, 23:41 UTC

News

Coherus BioSciences announced a special dividend of contingent value rights, boosting shares in after-market trading following the company's strategic asset sale initiative.

17 ago 2026, 23:41 UTC

News
Social Media

XP Inc shares are lower in after-market hours after announcing a share cancellation and reporting mixed Q2 results, including adjusted net profit above estimates.

17 ago 2026, 23:36 UTC

News

Whirlpool Corp is identified as a sell by Yahoo Finance amid concerns over declining sales and profitability. Shares are trading lower in after-market hours.

17 ago 2026, 23:36 UTC

News

Enovix Corp shares are rising in after-market trading, rebounding from recent lows amid leadership changes and broader market declines for the Dow and S&P 500.

17 ago 2026, 23:31 UTC

News

Fred Stephan named President and CEO effective November 1, 2026.

17 ago 2026, 23:31 UTC

News

Zeta Global shares are lower in after-market hours, despite positive coverage highlighting strong performance and anticipated revenue growth of 25.1%.

17 ago 2026, 23:21 UTC

News

AT&T Inc. shares are higher in after-market trading following a successful €1.2 billion and $1.1 billion notes issuance to enhance liquidity and capital structure.

17 ago 2026, 23:16 UTC

News

Patterson-UTI Energy highlighted in Yahoo Finance cautionary analysis

17 ago 2026, 23:16 UTC

Social Media
News

Wendy's Co. shares are lower in after-market hours following the announcement of President Pete Suerken's resignation and a restructuring plan.

17 ago 2026, 23:16 UTC

News

Valero Energy shares are higher in after-market hours following analyst upgrades and price target increases amid rising crude oil prices linked to Middle East tensions.

17 ago 2026, 23:11 UTC

News

Nasdaq Inc plans to extend U.S. trading hours to nearly 23 hours daily starting December 6, 2026, pending regulatory approval. Shares are higher in after-market trading.

17 ago 2026, 23:06 UTC

News

DigitalOcean Holdings Inc. launched Managed AI Agents via Cloudways, contributing to shares trading higher after the market closed.

17 ago 2026, 23:01 UTC

News

Mitek Systems appoints Aaron Seyler as Chief Revenue Officer, effective August 17, 2026. Shares are trading higher in after-market hours.

17 ago 2026, 23:01 UTC

News

CACI awarded a contract worth up to $981 million with the U.S. Space Force, yet shares are trading lower in after-market hours.

17 ago 2026, 23:01 UTC

News

Targa Resources has secured long-term midstream agreements with ExxonMobil and plans to invest $5 billion in new projects, driving shares higher in after-market trading.

17 ago 2026, 23:01 UTC

News

Becton Dickinson appoints Gary Sorsher as executive vice president and chief quality officer, effective September 8. Shares are higher in after-market trading.

17 ago 2026, 23:01 UTC

News

Science Applications International Corp is under scrutiny after being flagged by Yahoo Finance. Shares are lower in after-hours trading following concerns over revenue projections.

17 ago 2026, 23:01 UTC

Correlated Moves
News
Social Media

iShares 20+ Year Treasury Bond ETF gains in after-market trading, reflecting market sentiment influenced by rising crude oil prices amid geopolitical tensions.

17 ago 2026, 23:01 UTC

News
Correlated Moves

BlackRock Inc shares declined in after-market trading, continuing a trend of lower daily closes amid geopolitical tensions and rising crude oil prices.

17 ago 2026, 22:56 UTC

Correlated Moves
News

Kulicke and Soffa Industries shares are lower in after-market trading following the announcement of Dr. Raj Talluri as the new CEO, effective September 2026.

17 ago 2026, 22:56 UTC

News

ComEd allocates over $170,000 to enhance public safety in 24 Illinois communities through its Powering Safe Communities Program. Exelon shares are higher in after-market trading.

17 ago 2026, 22:51 UTC

Social Media
News

Kura Oncology shares rose in after-market trading after CEO Troy Wilson's $1.11 million stock purchase and positive earnings report highlighting $9.1 million in revenue.

17 ago 2026, 20:07 UTC

News

Levi Strauss faces analyst skepticism over revenue performance and cash flow margins. The consensus price target is $28.27, implying a potential return of 26.2%.

17 ago 2026, 20:07 UTC

News
Correlated Moves

The iShares 7-10 Year Treasury Bond ETF is trading lower amid rising 10-year Treasury yields and geopolitical tensions affecting economic growth and inflation expectations.

Comparación entre iguales

Cambio de precio

Takeda Pharmaceutical Co Ltd ADR previsión

Precio Objetivo

By TipRanks

80.43% repunte

Estimación a 12 Meses

Media 31.81 USD  80.43%

Máximo 42.629 USD

Mínimo 21 USD

De acuerdo con 2 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Takeda Pharmaceutical Co Ltd ADR Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

2 ratings

2

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Takeda Pharmaceutical Co Ltd ADR

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc., Seagen Inc., Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc., Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr. Falk Pharma, Exelixis, Inc., GlaxoSmithKline, Heidelberg Pharma, HUTCHMED, Presage Biosciences, Codexis, Inc., Ensoma, Envozyne, KM Biologics, and Selecta BioScience, and Ovid Therapeutics Inc.; and collaboration with ZEDIRA GmbH and Dr. Falk Pharma GmbH. It has research collaboration and licensing agreement with Crescendo Biologics, Code Bio, Immusoft, Poseida Therapeutics, and Selecta Biosciences. The company was founded in 1781 and is headquartered in Tokyo, Japan.